Tivic Health Seeks Share Increase, Director Election at Annual Meeting
Ticker: TIVC · Form: DEF 14A · Filed: Jun 2, 2025 · CIK: 1787740
Sentiment: mixed
Topics: Proxy Statement, Equity Incentive Plan, Stock Dilution, Corporate Governance, Nasdaq Compliance, Annual Meeting, Electromedical Apparatus
Related Tickers: TIVC
TL;DR
**TIVC is gearing up for potential dilution with a proposed 425,000 share increase for its equity plan, so watch for impact on share price.**
AI Summary
Tivic Health Systems, Inc. (TIVC) filed a DEF 14A on June 2, 2025, outlining proposals for its Annual Meeting of Stockholders on June 30, 2025. Key proposals include the election of one Class I director to serve until the 2028 annual meeting. The company also seeks approval to amend its Amended and Restated 2021 Equity Incentive Plan, increasing the authorized shares for issuance by 425,000 shares. Stockholders will also vote on ratifying Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Furthermore, TIVC is requesting approval, in accordance with Nasdaq Listing Rules 5635(a) and 5635(d), for the issuance of common stock, including shares convertible from Series A Non-Voting Convertible Preferred Stock. The meeting will be held virtually at www.virtualshareholdermeeting.com/TIVC2025 at 1:00 p.m. Pacific Time.
Why It Matters
This DEF 14A filing is crucial for investors as it details proposals that could significantly impact TIVC's capital structure and governance. The proposed increase of 425,000 shares in the 2021 Equity Incentive Plan could lead to dilution for existing shareholders, while also providing incentives for employee retention and recruitment in a competitive electromedical market. Approving the issuance of common stock from Series A Preferred Stock conversions is vital for the company's financing strategy and compliance with Nasdaq listing rules. For employees, the equity plan expansion signals continued investment in talent, potentially boosting morale and long-term commitment.
Risk Assessment
Risk Level: medium — The proposed increase of 425,000 shares for the 2021 Equity Incentive Plan presents a medium risk of dilution for existing shareholders. Additionally, the approval for issuing common stock upon conversion of Series A Non-Voting Convertible Preferred Stock, while necessary for compliance, could also contribute to share dilution.
Analyst Insight
Investors should carefully evaluate the potential dilutive effects of the proposed 425,000 share increase in the 2021 Equity Incentive Plan and the conversion of Series A Preferred Stock. Consider voting against these proposals if you are concerned about immediate shareholder value, or support them if you believe the long-term benefits of employee incentives and financing outweigh the dilution.
Key Numbers
- 425,000 shares — Increase in 2021 Equity Incentive Plan (Represents potential dilution for existing shareholders)
- June 30, 2025 — Annual Meeting Date (Date for key stockholder votes)
- 1:00 p.m. Pacific Time — Annual Meeting Time (Scheduled start time for the virtual meeting)
Key Players & Entities
- Tivic Health Systems, Inc. (company) — Registrant for DEF 14A filing
- Rosenberg Rich Baker Berman, P.A. (company) — Proposed independent registered public accounting firm
- Nasdaq Listing Rule 5635(a) (regulator) — Rule governing stock issuance approval
- Nasdaq Listing Rule 5635(d) (regulator) — Rule governing stock issuance approval
- 425,000 shares (dollar_amount) — Proposed increase in authorized shares for 2021 Equity Incentive Plan
- June 30, 2025 (date) — Date of the Annual Meeting of Stockholders
- December 31, 2025 (date) — End of fiscal year for accounting firm ratification
- Series A Non-Voting Convertible Preferred Stock (company) — Stock type whose conversion to common stock requires approval
FAQ
What is Tivic Health Systems, Inc. proposing for its 2021 Equity Incentive Plan?
Tivic Health Systems, Inc. is proposing to amend its Amended and Restated 2021 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 425,000 shares.
When is the Tivic Health Systems, Inc. 2025 Annual Meeting of Stockholders?
The 2025 Annual Meeting of Stockholders for Tivic Health Systems, Inc. will be held on Monday, June 30, 2025, at 1:00 p.m. Pacific Time.
How can stockholders attend the Tivic Health Systems, Inc. Annual Meeting?
Stockholders can attend the Annual Meeting virtually via the Internet at www.virtualshareholdermeeting.com/TIVC2025, where they can vote electronically and submit questions.
What accounting firm is Tivic Health Systems, Inc. seeking to ratify?
Tivic Health Systems, Inc. is seeking to ratify the selection of Rosenberg Rich Baker Berman, P.A. as its independent registered public accounting firm for the fiscal year ending December 31, 2025.
Why is Tivic Health Systems, Inc. seeking approval for common stock issuance related to Series A Preferred Stock?
Tivic Health Systems, Inc. is seeking approval in accordance with Nasdaq Listing Rule 5635(a) and Nasdaq Listing Rule 5635(d) for the issuance of shares of common stock, including upon conversion of shares of Series A Non-Voting Convertible Preferred Stock, to ensure compliance with listing requirements.
What is the primary purpose of the Tivic Health Systems, Inc. DEF 14A filing?
The primary purpose of the Tivic Health Systems, Inc. DEF 14A filing is to provide stockholders with information regarding the proposals to be voted upon at the 2025 Annual Meeting, including director election, equity plan amendments, and auditor ratification.
What is the potential impact of the proposed equity plan amendment on Tivic Health Systems, Inc. shareholders?
The proposed amendment to increase authorized shares by 425,000 for the 2021 Equity Incentive Plan could lead to dilution for existing shareholders, as more shares become available for issuance.
Which class of director is Tivic Health Systems, Inc. electing at the annual meeting?
Tivic Health Systems, Inc. is electing one Class I director to hold office until its 2028 annual meeting of stockholders.
What is the fiscal year end for Tivic Health Systems, Inc.?
The fiscal year end for Tivic Health Systems, Inc. is December 31.
Where is Tivic Health Systems, Inc.'s business address?
Tivic Health Systems, Inc.'s business address is 47685 Lakeview Blvd., Fremont, CA 94538.
Industry Context
Tivic Health Systems operates in the electromedical and electrotherapeutic apparatus industry. This sector is characterized by rapid technological advancements, significant research and development investment, and a complex regulatory environment overseen by bodies like the FDA. Companies in this space often focus on developing innovative medical devices for diagnosis, treatment, and patient monitoring, facing competition from both established players and emerging startups.
Regulatory Implications
The company's reliance on Nasdaq listing rules (5635(a) and 5635(d)) for stock issuance approval highlights the importance of maintaining compliance with exchange regulations. Failure to adhere to these rules could lead to delisting or other sanctions. Additionally, as a medical device company, TIVC is subject to stringent FDA regulations regarding product development, approval, and marketing, which carry significant compliance burdens and risks.
What Investors Should Do
- Review the proposals for the Annual Meeting.
- Vote on the election of the Class I director.
- Consider the impact of the 425,000 share increase to the 2021 Equity Incentive Plan.
- Vote to ratify Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm.
- Evaluate the necessity and impact of approving stock issuances under Nasdaq Listing Rule 5635.
Key Dates
- 2025-06-30: 2025 Annual Meeting of Stockholders — Stockholders will vote on key proposals including director election, equity plan amendment, auditor ratification, and stock issuance approval.
- 2025-12-31: Fiscal Year End — The independent registered public accounting firm is being ratified for this fiscal year.
Glossary
- DEF 14A
- A Definitive Proxy Statement filed with the SEC by a company to solicit proxies from shareholders for an annual or special meeting. (This document contains the proposals and information shareholders will vote on at the Annual Meeting.)
- Amended and Restated 2021 Equity Incentive Plan
- A company plan that allows for the granting of stock options, restricted stock, and other equity awards to employees and directors. (Shareholders are being asked to approve an increase in the number of shares authorized under this plan, which could lead to dilution.)
- Independent registered public accounting firm
- An external audit firm hired by a company to audit its financial statements and provide an opinion on their fairness and accuracy. (Shareholders are asked to ratify the selection of Rosenberg Rich Baker Berman, P.A. for the fiscal year ending December 31, 2025.)
- Nasdaq Listing Rule 5635(a) and 5635(d)
- Nasdaq rules that generally require shareholder approval for certain issuances of stock, particularly those that could result in a significant dilution of existing shareholders' ownership. (Tivic Health Systems is seeking approval under these rules for the issuance of common stock, including conversions from preferred stock.)
- Series A Non-Voting Convertible Preferred Stock
- A class of preferred stock that does not carry voting rights but can be converted into a specified number of shares of common stock. (The potential conversion of this preferred stock into common stock is part of the reason for seeking approval under Nasdaq Listing Rule 5635.)
Year-Over-Year Comparison
This filing is a DEF 14A for the 2025 Annual Meeting. As it is a proxy statement for an upcoming meeting, it does not contain comparative financial data from a prior year's filing. However, it does propose an increase of 425,000 shares to the equity incentive plan, which represents a potential future dilution event for shareholders. The ratification of the accounting firm and the approval of stock issuances under Nasdaq rules are key items for shareholder consideration.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on June 2, 2025 regarding Tivic Health Systems, Inc. (TIVC).